Literature DB >> 15242955

HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs.

Wassim Y Almawi1, Marc Busson, Hala Tamim, Einas M Al-Harbi, Ramzi R Finan, Saria F Wakim-Ghorayeb, Ayesha A Motala.   

Abstract

The gene frequencies of HLA class II alleles were studied in 95 healthy Lebanese Arab and 72 healthy Bahraini Arab subjects. Our aim was to establish the genetic relationship between Bahraini and Lebanese Arabs in terms of HLA class II gene and haplotype frequencies and to compare these results with frequencies for other countries with populations of Caucasian and non-Caucasian descent. Subjects were unrelated and of both sexes, and HLA-DRB1 and -DQB1 genotyping was done by the PCR sequence-specific primer technique. Comparative analysis of the HLA-DR and -DQ alleles revealed differences in the allelic distribution among Bahraini and Lebanese subjects. Analysis of the 25 HLA-DRB1 alleles that have been investigated showed that the DRB1*040101 and DRB1*110101 alleles were more frequent among Lebanese, whereas DRB1*030101 and DRB1*160101 alleles were more frequent among Bahrainis. Similarly, of the seven HLA-DQB1 alleles analyzed, the presence of DQB1*0201 was more frequent among Bahrainis, whereas DQB1*030101 was more frequent among Lebanese. The DRB1*160101-DQB1*050101 (0.1318 versus 0.0379%) and DRB1*030101-DQB1*0201 (0.1202 versus 0.0321%) haplotypes were more frequent among Bahrainis, while the DRB1*110101-DQB1*030101 (0.3142 versus 0.1198%) and DRB1*040101-DQB1*0302 (0.1416 versus 0.0278%) haplotypes were more frequent in Lebanese subjects. Furthermore, a high prevalence of the DRB1*040101-DRB1*110101-DQB1*0302-DQB1*030101 (12.63 versus 1.35%, P = 0.015) and the homozygous DRB1*110101-DRB1*110101-DQB1*030101-DQB1*030101 (7.37 versus 0.00%, P = 0.046) genotypes was seen among Lebanese, and DRB1*070101-DRB1*160101-DQB1*0201-DQB1*050101 (6.76 versus 0.00%, P = 0.034) was seen more frequently among Bahraini subjects. Our results underline significant differences between these two populations in HLA class II distribution, provide basic information for further studies of major histocompatibility complex heterogeneity among Arabic-speaking countries, and serve as a reference for further anthropological studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242955      PMCID: PMC440602          DOI: 10.1128/CDLI.11.4.770-774.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  31 in total

1.  Molecular analysis of HLA-DRB1, -DQA1 and -DQB1 polymorphism in Turkey.

Authors:  G Saruhan-Direskeneli; F A Uyar; S Bakar; M Eraksoy
Journal:  Tissue Antigens       Date:  2000-02

2.  Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population.

Authors:  A Amirzargar; J Mytilineos; S Farjadian; M Doroudchi; S Scherer; G Opelz; A Ghaderi
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

3.  DRB1*03 diversity and DRB3 associations in five major population groups in the United States.

Authors:  Ting F Tang; Jiun Wang; Rebecca Slack; Yu Su Lin; Li Li; Uwe Heine; Jennifer Ng; Robert J Hartzman; Carolyn Katovich Hurley
Journal:  Hum Immunol       Date:  2002-03       Impact factor: 2.850

4.  HLA alleles and haplotypes in the Turkish population: relatedness to Kurds, Armenians and other Mediterraneans.

Authors:  A Arnaiz-Villena; M Karin; N Bendikuze; E Gomez-Casado; J Moscoso; C Silvera; F S Oguz; A Sarper Diler; A De Pacho; L Allende; J Guillen; J Martinez Laso
Journal:  Tissue Antigens       Date:  2001-04

5.  Characteristics of rheumatoid arthritis relative to HLA-DR in Saudi Arabia.

Authors:  A S Al-Arfaj
Journal:  Saudi Med J       Date:  2001-07       Impact factor: 1.484

6.  Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations.

Authors:  P Sánchez-Velasco; N S Karadsheh; A García-Martín; C Ruíz de Alegría; F Leyva-Cobián
Journal:  Hum Immunol       Date:  2001-09       Impact factor: 2.850

7.  HLA polymorphism in type 1 diabetes Tunisians.

Authors:  H Abid Kamoun; S Hmida; H Kaabi; A Abid; H Slimane Houissa; M Maamar; N Mojaat; L Ben Hamed; A Dridi; M Kamoun Zribi; K Nagati; A Haddad; K Boukef
Journal:  Ann Genet       Date:  2002 Jan-Mar

8.  Hispano-Indian admixture in Paraguay studied by analysis of HLA-DRB1 polymorphism.

Authors:  O Benitez; P Loiseau; M Busson; C Dehay; J Hors; F Calvo; M Durand Mura; D Charron
Journal:  Pathol Biol (Paris)       Date:  2002-02

9.  Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans.

Authors:  Y S Park; C Y Wang; K W Ko; S W Yang; M Park; M C Yang; J X She
Journal:  Hum Immunol       Date:  1998-12       Impact factor: 2.850

10.  Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.

Authors:  Jeffrey E Lee; Joseph Abdalla; Geoffrey A Porter; Loretta Bradford; Elizabeth A Grimm; John D Reveille; Paul F Mansfield; Jeffrey E Gershenwald; Merrick I Ross
Journal:  Ann Surg Oncol       Date:  2002-07       Impact factor: 5.344

View more
  11 in total

1.  The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism.

Authors:  Shirin Farjadian; Massao Ota; Hidetoshi Inoko; Abbas Ghaderi
Journal:  Mol Biol Rep       Date:  2008-11-02       Impact factor: 2.316

2.  HLA class II alleles: susceptibility or resistance to cystic echinococcosis in Yemeni patients.

Authors:  Abdul-Basit A Al-Ghoury; Eman M El-Hamshary; Ahmed A Azazy; Eman M Hussein; Hanan Z Rayan
Journal:  Parasitol Res       Date:  2010-04-28       Impact factor: 2.289

3.  Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon.

Authors:  Wassim Y Almawi; Saria F Wakim-Ghorayeb; Mona R Arekat; Pierre Najm; Sose H Keleshian; Nasreen Al-Sayed; Bruno Blanchon; Hanady R Samaha; Noha Irani-Hakime
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

4.  Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease.

Authors:  Wenjie Sun; Ying Cui; Lihui Zhen; Lijuan Huang
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

Review 5.  Prevention or acceleration of type 1 diabetes by viruses.

Authors:  Liana Ghazarian; Julien Diana; Yannick Simoni; Lucie Beaudoin; Agnès Lehuen
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Lebanese and their relatedness to neighboring and distant populations.

Authors:  Wassim Y Almawi; Rita Nemr; Ramzi R Finan; F Lisa Saldhana; Abdelhafidh Hajjej
Journal:  BMC Genomics       Date:  2022-06-20       Impact factor: 4.547

7.  Influence of common and specific HLA-DRB1/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to type 1 diabetes.

Authors:  Mouna Stayoussef; Jihen Benmansour; Fayza A Al-Jenaidi; Rita Nemr; Muhallab E Ali; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

8.  Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients.

Authors:  Marwan Adwan
Journal:  Arch Rheumatol       Date:  2018-03-23       Impact factor: 1.472

9.  The Association between Human Leukocyte Antigen Class II DR3-DQ2 Haplotype and Type 1 Diabetes in Children of the East Azerbaijan State of Iran.

Authors:  Sima Mansoori Derakhshan; Fatemeh Zeinali Sehrig; Nasrin Sohrabi; Siamak Shiva; Behzad Baradaran; Mahmoud Shekari Khaniani
Journal:  Iran Red Crescent Med J       Date:  2015-09-28       Impact factor: 0.611

10.  The genetic heterogeneity of Arab populations as inferred from HLA genes.

Authors:  Abdelhafidh Hajjej; Wassim Y Almawi; Antonio Arnaiz-Villena; Lasmar Hattab; Slama Hmida
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.